Upcoming virtual conferences:
State of the Art in Cord Blood Transplantation: Banking, Expansion and Future Horizons
|A Joint Session with:|
MAY 27 – 15:30 EDT
Cord Blood (CB) has unique properties and advantages, including a strong anti-tumor effect. This session will focus on how the use of cryopreserved cord blood cells is changing from the standard transplant to engineered stem cells and T cells directed to viral or disease specific targets. The future of cord blood banking and the new strategies to overcome the main limitations of the stem cell content (including the results of phase II and phase III clinical trials) will be discussed to provide a broad overview of new cord blood applications.